Corporate Information And Statement Of Ifrs Compliance [Abstract]

Alligator Bioscience - Filing #690835

Concept	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2021-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	Alligator Bioscience AB	—	—
Domicile of entity	Sverige	—	—
Legal form of entity	publikt aktiebolag	—	—
Country of incorporation	Sve	—	—
Address of entity's registered office	Medicon Village, Scheel	—	—
Description of nature of entity's operations and principal activities	behan	—	—
Statement of IFRS compliance [text block]	-	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade receivables	—	13 930 SEK	7 446 SEK
Current trade payables	—	13 343 SEK	9 367 SEK
Explanation of sources of estimation uncertainty with significant risk of causing material adjustment	Osäkerheter i uppskattningar innebär en betydande risk för att tillgångars eller skulders värde kan	—	—
Disclosure of assets and liabilities with significant risk of material adjustment [text block]	3. Viktiga uppskattningar och bedömningar	—	—
Disclosure of objectives, policies and processes for managing capital [text block]	5. Kapitalhantering	—	—